GCG and fatty liver disease: Fasting glucagon concentrations, which are consistent with the presence of hepatic steatosis [29], were increased in the type 2 diabetes group (p<0.001) and tended to be greater in Obese-NGT (p=0.053) compared with Lean-NGT, with no difference between Obese-NGT vs the type 2 diabetes group (Table 1).